Elago, Theodora V.
HRN: 06-68-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
CEFUROXIME 1.5GM (VIAL)
03/28/2024
04/04/2024
IV
1.5g
Q8
Empiric
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes